.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Accenture
US Army
Harvard Business School
Federal Trade Commission
Novartis
Cantor Fitzgerald
QuintilesIMS
Cipla
Teva

Generated: December 13, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 091031

« Back to Dashboard

NDA 091031 describes CEFOTETAN, which is a drug marketed by Fresenius Kabi Usa, Hikma Farmaceutica, West-ward Pharm Corp, and B Braun, and is included in five NDAs. It is available from two suppliers. Additional details are available on the CEFOTETAN profile page.

The generic ingredient in CEFOTETAN is cefotetan disodium. There are three drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the cefotetan disodium profile page.

Summary for 091031

Tradename:1
Applicant:1
Ingredient:1
Patents:0

Pharmacology for NDA: 091031

Ingredient-typeCephalosporins

Medical Subject Heading (MeSH) Categories for 091031

Suppliers and Packaging for NDA: 091031

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CEFOTETAN cefotetan disodium INJECTABLE;INJECTION 091031 ANDA West-Ward Pharmaceuticals Corp 0143-9670 0143-9670-10 10 VIAL in 1 CARTON (0143-9670-10) > 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0143-9670-01)
CEFOTETAN cefotetan disodium INJECTABLE;INJECTION 091031 ANDA West-Ward Pharmaceuticals Corp 0143-9671 0143-9671-10 10 VIAL in 1 CARTON (0143-9671-10) > 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0143-9671-01)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrengthEQ 1GM BASE/VIAL
Approval Date:Oct 26, 2011TE:APRLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrengthEQ 2GM BASE/VIAL
Approval Date:Oct 26, 2011TE:APRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

QuintilesIMS
US Department of Justice
Cantor Fitzgerald
Colorcon
Citi
Cerilliant
Fish and Richardson
Boehringer Ingelheim
Fuji
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot